Home
Qilu-Pharma

Qilu-Pharma Market Share Analysis for November 2025

齐鲁制药 | 用科技表达我们的爱_齐鲁制药是中国大型综合性现代制药企业，主要研制、生产与销售抗肿瘤药，心脑血管药，抗感染药，呼吸系统药，精神系统用药。

Health > Biotechnology and Pharmaceuticals

Domainqilu-pharma.com

Year Founded--

Employees> 10001

Annual Revenue$5M - $10M

Qilu-Pharma

Qilu-Pharma (including company regionals)

qilu-pharma.com

See more website traffic and engagement information

Qilu-Pharma Revenue up to November 2025 is 5M - 10M

revenue generated by Qilu-Pharma top domains

Qilu-Pharma top domains revenue over 3 years

Revenue for Qilu-Pharma top domains

qilu-pharma.com5M - 10M

See more with Sales Intelligence

Total visits to Qilu-Pharma's top domains

Understand Qilu-Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

qilu-pharma.com94.9K

See more with Sales Intelligence

Avg. visit duration in Qilu-Pharma's top domains

Analyze Qilu-Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

qilu-pharma.com00:07:57

See more with Sales Intelligence

Avg. pageviews on Qilu-Pharma's top domains

See how Qilu-Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

qilu-pharma.com8.07

See more with Sales Intelligence

Qilu-Pharma top competitors by domain

Top similar sites in November 2025, ranked by their affinity

novartis.comCompany NameNovartisEmployees> 10001HQSwitzerland, BaselAnnual revenue> $1BTotal visits1.4MHealth > Biotechnology and Pharmaceuticals

Top technologies used by Qilu-Pharma

These are the website technologies, by industry, used by Qilu-Pharma top domains

Mobile (3)

Meta Viewport

Advertising (1)

PubMatic

Multilingual (1)

Multilingual Support

Social (1)

Baidu Share

More Technologies

1

See all

News & Signals from Qilu-Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLaekna, Inc. partners with Qilu Pharma Group.Laekna entered into an exclusive licensing agreement with Qilu Pharma for LAE002 (AFURESERTIB), an innovative drug candidate for the treatment of breast cancer in China.

NewsMinghui Pharmaceutical Ltd. partnered with Qilu Pharma Group on May 9th '25.SHANGHAI, China I May 9, 2025 I Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the development, manufacturing, and commercialization of its B7-H3 ADC (MHB088C) in Greater China (including Mainland China, Hong Kong, Macau, and Taiwan).

NewsQilu Pharma Group invests into Arbutus Biopharma Corporation $15M.Furthermore, Qilu invested $15 million in equity in Arbutus at a cost of $4.19 a share.